MODERN METHODS OF DIAGNOSTICS AND TREATMENT OF CHLAMYDIA INFECTION

Abstract

The review reflects the current understanding of the etiology, pathogenesis, and treatment of chlamydia. The advantages of new methods for the diagnosis of chlamydial infection using methods such as real-time polymerase chain reaction (PCR-RV) and real-time NASBA transcription amplification (NASBA-Real-Time) are described. Comparison with older methods, such as bacteriological, immunomorphological and immunological, has been made; diagnostic and treatment algorithms for chlamydial infection in pregnant women have been compiled.

Keywords

NASBA-Real-Time / chlamydial infection / nucleic acid amplification techniques (NAAT) / PCR-RV / NASBA-Real-Time / azithromycin / pregnant women / chlamydial conjunctivitis

References

[1] Федеральные клинические рекомендации по ведению больных хламидийной инфекцией. М.; 2015

[2] Stamm W.E. et al. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Philadelphia; 2010

[3] Дмитриев Г.А. Урогенитальная хламидийная инфекция. Подходы к диагностике и терапии. Инфекции, передаваемые половым путём. 2002; 2: 21-4

[4] Koroku M., Kumamoto Y., Hirose T. et al. Epidemiologic study of Chlamydia trachomatis infection in pregnant women. Sex Transm. Dis. 2004; 21 (6): 329-31.

[5] Nelson H.D., Helfand M. Screening for chlamydial infection. Am. J. Prev. Med. 2001; 20 (3): 95-107.

[6] Paavonen J., Eggert-Kruse W. Chlamydia trachomatis: impact on human reproduction. Human Reprod. Updare. 1999; 5: 433-47.

[7] Gaydos C.A., Howell M.R., Pare B. et al. Chlamydia trachomatis infection in female military recruits. N. Engl. J. Med. 1998; 339: 739-44.

[8] Geisler W.M., Yu S., Hook E.W. III. Chlamydial and gonococcal infection in men without polymorphnonuclear leucocytes on Gram Stain. Sex Transm. Dis. 2005; 32: 630-4.

[9] Серов В.Н., Тютюнник В.Л., Ефимов Б.А., Зубков В.В. Новейшие принципы терапии урогенитального хламидиоза. Русский медицинский журнал. 2011; (20): 1244-9

[10] Westrom L.V. Sexually transmitted diseases and infertility. Sex. Transm. Dis. 1994; 21: S32-S37

[11] Савичева А.М., Башмакова М.А. Урогенитальный хламидиоз у женщин и его последствия. М.: Медицинская книга; 1998.

[12] Кисина В.И., Забиров К.И. Урогенитальные инфекции у женщин. Клиника. Диагностика. Лечение. М.; 2005.

[13] Papp J.R., Schachter J., Gaydos C. et al. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae - 2014. MMWR Recomm. Rep. 2014; 63(No. RR-02).

[14] Masek B.J., Arora N., Quinn N. et al. Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program. J. Clin. Microbiol. 2009; 47: 1663-7.

[15] Knox J., Tabrizi S.N., Miller P. et al. Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas. Sex Transm. Dis. 2002; 29: 647-54.

[16] Schachter J., Chernesky M.A., Willis D.E. et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm. Dis. 2005; 32: 725-8.

[17] Doshi J.S., Power J., Allen E. Acceptability of chlamydia screening using self-taken vaginal swabs. Intern. J. of STD and AIDS. 2008;19: 507-9.

[18] Гущин А.Е., Шипулин Г.А. Современные методы амплификации нуклеиновых кислот ПЦРиреакция транскрипционной амплификации НАСБАвреальном вреиени - эффективные инструменты лабораторной диагностики урогенитальной хламидийной инфекции. В кн.: Сб. трудов 6-й Всероссийской научно-практической конференции с международным участием «Молекулярная диагностика - 2007». М., 2007; 2: 161-74

[19] Black C.M. Current Methods of Laboratory Diagnosis of Chlamydia trachomatis Infection. Clin. Microbiol. Rev. 1997; 10: 160-84.

[20] Welsh L.E., Quinn T.C., Gaydos Ch.A. Influence of endocervical adequacy on PCR and DFA for detection of C. trachomatis. J. Clin. Microbiol. 1997; 35(2): 3078-81.

[21] Battle T.M., Golden M.R., Suchland K.L., Counts J.M., Hughes J.P., Stamm W.E., Holmes K.K. Evaluation of laboratory testing methods for C. trachomatis in the era of NAAT. J. Clin. Microbiol. 2001; 39(8): 2924-7.

[22] Scholes D., Stergachis A., Heidrich F.E., Andrilla H., Holmes K.K., Stamm W.E. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N. Engl. J. Med. 1996; 334(21): 1362-6.

[23] Higuchi R., Fockler C., Dollinger G., Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reaction. Biotechnology (NY). 1993; 11: 1026-30.

[24] Geisler W.M., Suchland R.J., Whittington W.L., Stamm W.E. Quantitative culture of C. trachomatis: relation to clinical manifestation. J. Infect. Dis. 2001; 184: 1350-4.

[25] Morre S., Sillekens P., Jacobs M.V. et al. RNA amplification by nucleic acid sequence-based amplification with an internal standard enables reliable detection of Chlamydia trachomatis in cervical scrapings and urine samples. J. Clin. Microbiol. 1996; 34: 3108-14.

[26] Фриго Н.В., Ротанов С.В., Лесная И.Н., Полетаева О.А., Полевщикова С.А. Лабораторная диагностика ИППП в Российской Федерации. Результаты национального исследования. Вестник дерматологии и венерологии. 2008; 5: 33-41.

[27] Кисина В.И., Гущин А.Е., Колиева Г.Л., Потекаев Н.Н. Урогенитальные инфекции, передаваемые половым путём: проблемы сложившейся практики ведения больных в дерматовенерологических учреждениях Москвы. Клиническая дерматология и венерология. 2013; 6: 67-71.

[28] Geisler W.M., Wang C., Morrison S.G. et al. The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm. Dis. 2008; 35:119-23.

[29] Lau C.Y., Qureshi A.K. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm. Dis. 2002; 29: 497-502.

[30] Hathorn E., Opie C., Goold P. What is the appropriate treatment for the management of rectal Chlamydia trachomatis in men and women? Sex Transm. Infect. 2012; 88: 352-4.

[31] Steedman N.M., McMillan A. Treatment of asymptomatic rectal Chlamydia trachomatis: is single-dose azithromycin effective? Intern. J. STD and AIDS. 2009; 20: 16-8.

[32] Geisler W.M., Koltun W.D., Abdelsayed N. et al. Safety and efficacy of WC2031 versus vibramycin for the treatment of uncomplicated urogenital Chlamydia trachomatis infection: a randomized, double-blind, double-dummy, active-controlled, multicenter trial. Clin. Infect. Dis. 2012; 55: 82-8.

[33] Briggs G.C., Freeman R.K., Yaffe S.J. Drugs in Pregnancy and Lactation. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011.

[34] Jacobson G.F., Autry A.M., Kirby R.S. et al. A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. Am. J. Obstet. Gynecol. 2001; 184: 1352-4.

[35] Kacmar J., Cheh E., Montagno A. et al. A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. Infect. Dis. Obstet. Gynecol. 2001; 9: 197-202.

[36] Rahangdale L., Guerry S., Bauer H.M. et al. An observational cohort study of Chlamydia trachomatis treatment in pregnancy. Sex Transm. Dis. 2006; 33: 106-10.

RIGHTS & PERMISSIONS

Eco-Vector